ANGIODYNAMICS INC - FORM 10-K - EX-23 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - August 12, 2011

Attached files

file filename
10-K - FORM 10-K - ANGIODYNAMICS INCd10k.htm
EX-21 - SUBSIDIARIES - ANGIODYNAMICS INCdex21.htm
EX-32.2 - CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION - ANGIODYNAMICS INCdex322.htm
EX-32.1 - CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION - ANGIODYNAMICS INCdex321.htm
EX-31.1 - CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - ANGIODYNAMICS INCdex311.htm
EX-31.2 - CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - ANGIODYNAMICS INCdex312.htm
EX-10.28 - ANGIODYNAMICS, INC. FISCAL YEAR 2011 SENIOR EXECUTIVE EQUITY INCENTIVE PROGRAM - ANGIODYNAMICS INCdex1028.htm
EX-10.27 - ANGIODYNAMICS, INC. FISCAL YEAR 2011 SENIOR EXECUTIVE CASH INCENTIVE PROGRAM - ANGIODYNAMICS INCdex1027.htm
EX-10.29 - ANGIODYNAMICS, INC. FISCAL YEAR 2012 SENIOR EXECUTIVE CASH INCENTIVE PROGRAM - ANGIODYNAMICS INCdex1029.htm
EX-10.30 - ANGIODYNAMICS, INC. FISCAL YEAR 2012 SENIOR EXECUTIVE EQUITY INCENTIVE PROGRAM - ANGIODYNAMICS INCdex1030.htm

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-120057, No. 333-138456, No. 333-140627, No. 333-161355, No. 333-162844 and No. 333-170619) of AngioDynamics, Inc. and Subsidiaries of our report dated August 12, 2011 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appear in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Albany, New York

August 12, 2011

Stock widget

Investing forum

ANGIODYNAMICS INC Reports